Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex
In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by...
Ausführliche Beschreibung
Autor*in: |
Hedayati, Mohammad T. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2019transfer abstract |
---|
Schlagwörter: |
---|
Umfang: |
8 |
---|
Übergeordnetes Werk: |
Enthalten in: Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling - Samra, Yara A. ELSEVIER, 2020, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:129 ; year:2019 ; pages:168-175 ; extent:8 |
Links: |
---|
DOI / URN: |
10.1016/j.micpath.2019.02.009 |
---|
Katalog-ID: |
ELV04612828X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV04612828X | ||
003 | DE-627 | ||
005 | 20230626013101.0 | ||
007 | cr uuu---uuuuu | ||
008 | 191021s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.micpath.2019.02.009 |2 doi | |
028 | 5 | 2 | |a GBV00000000000553.pica |
035 | |a (DE-627)ELV04612828X | ||
035 | |a (ELSEVIER)S0882-4010(19)30028-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a PHARM |q DE-84 |2 fid | ||
084 | |a 44.38 |2 bkl | ||
100 | 1 | |a Hedayati, Mohammad T. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex |
264 | 1 | |c 2019transfer abstract | |
300 | |a 8 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. | ||
520 | |a In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. | ||
650 | 7 | |a Antifungal susceptibility testing |2 Elsevier | |
650 | 7 | |a <ce:italic>Scedosporium</ce:italic> species |2 Elsevier | |
650 | 7 | |a Cystic fibrosis |2 Elsevier | |
650 | 7 | |a <ce:italic>Aspergillus</ce:italic> species |2 Elsevier | |
700 | 1 | |a Tavakoli, Mahin |4 oth | |
700 | 1 | |a Maleki, Maedeh |4 oth | |
700 | 1 | |a Heidari, Somaye |4 oth | |
700 | 1 | |a Mortezaee, Vida |4 oth | |
700 | 1 | |a Gheisari, Maryam |4 oth | |
700 | 1 | |a Hassanzad, Maryam |4 oth | |
700 | 1 | |a Mirenayat, Maryam Sadat |4 oth | |
700 | 1 | |a Mahdaviani, Seyed Alireza |4 oth | |
700 | 1 | |a Pourabdollah, Mihan |4 oth | |
700 | 1 | |a velayati, Ali Akbar |4 oth | |
700 | 1 | |a Vakili, Mahshid |4 oth | |
700 | 1 | |a Abastabar, Mahdi |4 oth | |
700 | 1 | |a Haghani, Iman |4 oth | |
700 | 1 | |a Jafarzadeh, Jalal |4 oth | |
700 | 1 | |a Hedayati, Newsha |4 oth | |
700 | 1 | |a Seyedmousavi, Seyedmojtaba |4 oth | |
700 | 1 | |a Alastruey-Izquierdo, Ana |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Samra, Yara A. ELSEVIER |t Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling |d 2020 |g Amsterdam [u.a.] |w (DE-627)ELV00536194X |
773 | 1 | 8 | |g volume:129 |g year:2019 |g pages:168-175 |g extent:8 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.micpath.2019.02.009 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
936 | b | k | |a 44.38 |j Pharmakologie |q VZ |
951 | |a AR | ||
952 | |d 129 |j 2019 |h 168-175 |g 8 |
author_variant |
m t h mt mth |
---|---|
matchkey_str |
hedayatimohammadttavakolimahinmalekimaed:2019----:uglpdmooynytcirssainsihseilouociaiseo |
hierarchy_sort_str |
2019transfer abstract |
bklnumber |
44.38 |
publishDate |
2019 |
allfields |
10.1016/j.micpath.2019.02.009 doi GBV00000000000553.pica (DE-627)ELV04612828X (ELSEVIER)S0882-4010(19)30028-2 DE-627 ger DE-627 rakwb eng 610 VZ PHARM DE-84 fid 44.38 bkl Hedayati, Mohammad T. verfasserin aut Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. Antifungal susceptibility testing Elsevier <ce:italic>Scedosporium</ce:italic> species Elsevier Cystic fibrosis Elsevier <ce:italic>Aspergillus</ce:italic> species Elsevier Tavakoli, Mahin oth Maleki, Maedeh oth Heidari, Somaye oth Mortezaee, Vida oth Gheisari, Maryam oth Hassanzad, Maryam oth Mirenayat, Maryam Sadat oth Mahdaviani, Seyed Alireza oth Pourabdollah, Mihan oth velayati, Ali Akbar oth Vakili, Mahshid oth Abastabar, Mahdi oth Haghani, Iman oth Jafarzadeh, Jalal oth Hedayati, Newsha oth Seyedmousavi, Seyedmojtaba oth Alastruey-Izquierdo, Ana oth Enthalten in Elsevier Samra, Yara A. ELSEVIER Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling 2020 Amsterdam [u.a.] (DE-627)ELV00536194X volume:129 year:2019 pages:168-175 extent:8 https://doi.org/10.1016/j.micpath.2019.02.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ AR 129 2019 168-175 8 |
spelling |
10.1016/j.micpath.2019.02.009 doi GBV00000000000553.pica (DE-627)ELV04612828X (ELSEVIER)S0882-4010(19)30028-2 DE-627 ger DE-627 rakwb eng 610 VZ PHARM DE-84 fid 44.38 bkl Hedayati, Mohammad T. verfasserin aut Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. Antifungal susceptibility testing Elsevier <ce:italic>Scedosporium</ce:italic> species Elsevier Cystic fibrosis Elsevier <ce:italic>Aspergillus</ce:italic> species Elsevier Tavakoli, Mahin oth Maleki, Maedeh oth Heidari, Somaye oth Mortezaee, Vida oth Gheisari, Maryam oth Hassanzad, Maryam oth Mirenayat, Maryam Sadat oth Mahdaviani, Seyed Alireza oth Pourabdollah, Mihan oth velayati, Ali Akbar oth Vakili, Mahshid oth Abastabar, Mahdi oth Haghani, Iman oth Jafarzadeh, Jalal oth Hedayati, Newsha oth Seyedmousavi, Seyedmojtaba oth Alastruey-Izquierdo, Ana oth Enthalten in Elsevier Samra, Yara A. ELSEVIER Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling 2020 Amsterdam [u.a.] (DE-627)ELV00536194X volume:129 year:2019 pages:168-175 extent:8 https://doi.org/10.1016/j.micpath.2019.02.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ AR 129 2019 168-175 8 |
allfields_unstemmed |
10.1016/j.micpath.2019.02.009 doi GBV00000000000553.pica (DE-627)ELV04612828X (ELSEVIER)S0882-4010(19)30028-2 DE-627 ger DE-627 rakwb eng 610 VZ PHARM DE-84 fid 44.38 bkl Hedayati, Mohammad T. verfasserin aut Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. Antifungal susceptibility testing Elsevier <ce:italic>Scedosporium</ce:italic> species Elsevier Cystic fibrosis Elsevier <ce:italic>Aspergillus</ce:italic> species Elsevier Tavakoli, Mahin oth Maleki, Maedeh oth Heidari, Somaye oth Mortezaee, Vida oth Gheisari, Maryam oth Hassanzad, Maryam oth Mirenayat, Maryam Sadat oth Mahdaviani, Seyed Alireza oth Pourabdollah, Mihan oth velayati, Ali Akbar oth Vakili, Mahshid oth Abastabar, Mahdi oth Haghani, Iman oth Jafarzadeh, Jalal oth Hedayati, Newsha oth Seyedmousavi, Seyedmojtaba oth Alastruey-Izquierdo, Ana oth Enthalten in Elsevier Samra, Yara A. ELSEVIER Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling 2020 Amsterdam [u.a.] (DE-627)ELV00536194X volume:129 year:2019 pages:168-175 extent:8 https://doi.org/10.1016/j.micpath.2019.02.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ AR 129 2019 168-175 8 |
allfieldsGer |
10.1016/j.micpath.2019.02.009 doi GBV00000000000553.pica (DE-627)ELV04612828X (ELSEVIER)S0882-4010(19)30028-2 DE-627 ger DE-627 rakwb eng 610 VZ PHARM DE-84 fid 44.38 bkl Hedayati, Mohammad T. verfasserin aut Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. Antifungal susceptibility testing Elsevier <ce:italic>Scedosporium</ce:italic> species Elsevier Cystic fibrosis Elsevier <ce:italic>Aspergillus</ce:italic> species Elsevier Tavakoli, Mahin oth Maleki, Maedeh oth Heidari, Somaye oth Mortezaee, Vida oth Gheisari, Maryam oth Hassanzad, Maryam oth Mirenayat, Maryam Sadat oth Mahdaviani, Seyed Alireza oth Pourabdollah, Mihan oth velayati, Ali Akbar oth Vakili, Mahshid oth Abastabar, Mahdi oth Haghani, Iman oth Jafarzadeh, Jalal oth Hedayati, Newsha oth Seyedmousavi, Seyedmojtaba oth Alastruey-Izquierdo, Ana oth Enthalten in Elsevier Samra, Yara A. ELSEVIER Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling 2020 Amsterdam [u.a.] (DE-627)ELV00536194X volume:129 year:2019 pages:168-175 extent:8 https://doi.org/10.1016/j.micpath.2019.02.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ AR 129 2019 168-175 8 |
allfieldsSound |
10.1016/j.micpath.2019.02.009 doi GBV00000000000553.pica (DE-627)ELV04612828X (ELSEVIER)S0882-4010(19)30028-2 DE-627 ger DE-627 rakwb eng 610 VZ PHARM DE-84 fid 44.38 bkl Hedayati, Mohammad T. verfasserin aut Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. Antifungal susceptibility testing Elsevier <ce:italic>Scedosporium</ce:italic> species Elsevier Cystic fibrosis Elsevier <ce:italic>Aspergillus</ce:italic> species Elsevier Tavakoli, Mahin oth Maleki, Maedeh oth Heidari, Somaye oth Mortezaee, Vida oth Gheisari, Maryam oth Hassanzad, Maryam oth Mirenayat, Maryam Sadat oth Mahdaviani, Seyed Alireza oth Pourabdollah, Mihan oth velayati, Ali Akbar oth Vakili, Mahshid oth Abastabar, Mahdi oth Haghani, Iman oth Jafarzadeh, Jalal oth Hedayati, Newsha oth Seyedmousavi, Seyedmojtaba oth Alastruey-Izquierdo, Ana oth Enthalten in Elsevier Samra, Yara A. ELSEVIER Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling 2020 Amsterdam [u.a.] (DE-627)ELV00536194X volume:129 year:2019 pages:168-175 extent:8 https://doi.org/10.1016/j.micpath.2019.02.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA 44.38 Pharmakologie VZ AR 129 2019 168-175 8 |
language |
English |
source |
Enthalten in Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling Amsterdam [u.a.] volume:129 year:2019 pages:168-175 extent:8 |
sourceStr |
Enthalten in Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling Amsterdam [u.a.] volume:129 year:2019 pages:168-175 extent:8 |
format_phy_str_mv |
Article |
bklname |
Pharmakologie |
institution |
findex.gbv.de |
topic_facet |
Antifungal susceptibility testing <ce:italic>Scedosporium</ce:italic> species Cystic fibrosis <ce:italic>Aspergillus</ce:italic> species |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling |
authorswithroles_txt_mv |
Hedayati, Mohammad T. @@aut@@ Tavakoli, Mahin @@oth@@ Maleki, Maedeh @@oth@@ Heidari, Somaye @@oth@@ Mortezaee, Vida @@oth@@ Gheisari, Maryam @@oth@@ Hassanzad, Maryam @@oth@@ Mirenayat, Maryam Sadat @@oth@@ Mahdaviani, Seyed Alireza @@oth@@ Pourabdollah, Mihan @@oth@@ velayati, Ali Akbar @@oth@@ Vakili, Mahshid @@oth@@ Abastabar, Mahdi @@oth@@ Haghani, Iman @@oth@@ Jafarzadeh, Jalal @@oth@@ Hedayati, Newsha @@oth@@ Seyedmousavi, Seyedmojtaba @@oth@@ Alastruey-Izquierdo, Ana @@oth@@ |
publishDateDaySort_date |
2019-01-01T00:00:00Z |
hierarchy_top_id |
ELV00536194X |
dewey-sort |
3610 |
id |
ELV04612828X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04612828X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626013101.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.micpath.2019.02.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000553.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04612828X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0882-4010(19)30028-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hedayati, Mohammad T.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antifungal susceptibility testing</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a"><ce:italic>Scedosporium</ce:italic> species</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cystic fibrosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a"><ce:italic>Aspergillus</ce:italic> species</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tavakoli, Mahin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maleki, Maedeh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heidari, Somaye</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mortezaee, Vida</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gheisari, Maryam</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hassanzad, Maryam</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mirenayat, Maryam Sadat</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahdaviani, Seyed Alireza</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pourabdollah, Mihan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">velayati, Ali Akbar</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vakili, Mahshid</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abastabar, Mahdi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Haghani, Iman</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jafarzadeh, Jalal</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hedayati, Newsha</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Seyedmousavi, Seyedmojtaba</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alastruey-Izquierdo, Ana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Samra, Yara A. ELSEVIER</subfield><subfield code="t">Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00536194X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:129</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:168-175</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.micpath.2019.02.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">129</subfield><subfield code="j">2019</subfield><subfield code="h">168-175</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
author |
Hedayati, Mohammad T. |
spellingShingle |
Hedayati, Mohammad T. ddc 610 fid PHARM bkl 44.38 Elsevier Antifungal susceptibility testing Elsevier <ce:italic>Scedosporium</ce:italic> species Elsevier Cystic fibrosis Elsevier <ce:italic>Aspergillus</ce:italic> species Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex |
authorStr |
Hedayati, Mohammad T. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV00536194X |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ PHARM DE-84 fid 44.38 bkl Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex Antifungal susceptibility testing Elsevier <ce:italic>Scedosporium</ce:italic> species Elsevier Cystic fibrosis Elsevier <ce:italic>Aspergillus</ce:italic> species Elsevier |
topic |
ddc 610 fid PHARM bkl 44.38 Elsevier Antifungal susceptibility testing Elsevier <ce:italic>Scedosporium</ce:italic> species Elsevier Cystic fibrosis Elsevier <ce:italic>Aspergillus</ce:italic> species |
topic_unstemmed |
ddc 610 fid PHARM bkl 44.38 Elsevier Antifungal susceptibility testing Elsevier <ce:italic>Scedosporium</ce:italic> species Elsevier Cystic fibrosis Elsevier <ce:italic>Aspergillus</ce:italic> species |
topic_browse |
ddc 610 fid PHARM bkl 44.38 Elsevier Antifungal susceptibility testing Elsevier <ce:italic>Scedosporium</ce:italic> species Elsevier Cystic fibrosis Elsevier <ce:italic>Aspergillus</ce:italic> species |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
m t mt m m mm s h sh v m vm m g mg m h mh m s m ms msm s a m sa sam m p mp a a v aa aav m v mv m a ma i h ih j j jj n h nh s s ss a a i aai |
hierarchy_parent_title |
Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling |
hierarchy_parent_id |
ELV00536194X |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV00536194X |
title |
Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex |
ctrlnum |
(DE-627)ELV04612828X (ELSEVIER)S0882-4010(19)30028-2 |
title_full |
Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex |
author_sort |
Hedayati, Mohammad T. |
journal |
Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling |
journalStr |
Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2019 |
contenttype_str_mv |
zzz |
container_start_page |
168 |
author_browse |
Hedayati, Mohammad T. |
container_volume |
129 |
physical |
8 |
class |
610 VZ PHARM DE-84 fid 44.38 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Hedayati, Mohammad T. |
doi_str_mv |
10.1016/j.micpath.2019.02.009 |
dewey-full |
610 |
title_sort |
fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>scedosporium</ce:italic> species complex |
title_auth |
Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex |
abstract |
In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. |
abstractGer |
In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. |
abstract_unstemmed |
In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-PHARM SSG-OLC-PHA SSG-OPC-PHA |
title_short |
Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex |
url |
https://doi.org/10.1016/j.micpath.2019.02.009 |
remote_bool |
true |
author2 |
Tavakoli, Mahin Maleki, Maedeh Heidari, Somaye Mortezaee, Vida Gheisari, Maryam Hassanzad, Maryam Mirenayat, Maryam Sadat Mahdaviani, Seyed Alireza Pourabdollah, Mihan velayati, Ali Akbar Vakili, Mahshid Abastabar, Mahdi Haghani, Iman Jafarzadeh, Jalal Hedayati, Newsha Seyedmousavi, Seyedmojtaba Alastruey-Izquierdo, Ana |
author2Str |
Tavakoli, Mahin Maleki, Maedeh Heidari, Somaye Mortezaee, Vida Gheisari, Maryam Hassanzad, Maryam Mirenayat, Maryam Sadat Mahdaviani, Seyed Alireza Pourabdollah, Mihan velayati, Ali Akbar Vakili, Mahshid Abastabar, Mahdi Haghani, Iman Jafarzadeh, Jalal Hedayati, Newsha Seyedmousavi, Seyedmojtaba Alastruey-Izquierdo, Ana |
ppnlink |
ELV00536194X |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
doi_str |
10.1016/j.micpath.2019.02.009 |
up_date |
2024-07-06T19:23:55.292Z |
_version_ |
1803858828636192768 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04612828X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626013101.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.micpath.2019.02.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000553.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04612828X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0882-4010(19)30028-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">PHARM</subfield><subfield code="q">DE-84</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.38</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hedayati, Mohammad T.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Fungal epidemiology in cystic fibrosis patients with a special focus on <ce:italic>Scedosporium</ce:italic> species complex</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In this present study, for the first time, we evaluated the cystic fibrosis (CF) patients for the Scedosporium species and their antifungal susceptibility against eight antifungal agents. During one-year period, 90 Sputum samples were collected from Iranian CF patients. All samples were evaluated by direct microscopic examination, culture onto four different media including Malt extract agar, Inhibitory mold agar, Brain Heart Infusion and Scedo-Select III. The mold isolated fungi were identified by PCR-Sequencing of ITS and β-tubulin genes. In-vitro antifungal susceptibility was performed according to the Clinical & Laboratory Standards Institute (CLSI) M38-A2 guidelines.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antifungal susceptibility testing</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a"><ce:italic>Scedosporium</ce:italic> species</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cystic fibrosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a"><ce:italic>Aspergillus</ce:italic> species</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tavakoli, Mahin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maleki, Maedeh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heidari, Somaye</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mortezaee, Vida</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gheisari, Maryam</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hassanzad, Maryam</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mirenayat, Maryam Sadat</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahdaviani, Seyed Alireza</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pourabdollah, Mihan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">velayati, Ali Akbar</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vakili, Mahshid</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Abastabar, Mahdi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Haghani, Iman</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jafarzadeh, Jalal</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hedayati, Newsha</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Seyedmousavi, Seyedmojtaba</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alastruey-Izquierdo, Ana</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Samra, Yara A. ELSEVIER</subfield><subfield code="t">Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV00536194X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:129</subfield><subfield code="g">year:2019</subfield><subfield code="g">pages:168-175</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.micpath.2019.02.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-PHARM</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.38</subfield><subfield code="j">Pharmakologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">129</subfield><subfield code="j">2019</subfield><subfield code="h">168-175</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
score |
7.4010277 |